Availability of clinical data through electronic trials have put downward pressure on the current analytical and reporting processes within clinical research and development.
Availability of clinical data through electronic trials have put downward pressure on the current analytical and reporting processes within clinical research and development.
Availability of clinical data through electronic trials have put downward pressure on the current analytical and reporting processes within clinical research and development.
Availability of clinical data through electronic trials have put downward
pressure on the current analytical and reporting processes within clinical research and development. Moreover, the EDCs have enabled the rapid ramp up of the use of adaptive clinical trials, which looking at early trends to assess the probability of success for the clinical trial or suggest a possible mid-course correction requiring greater use of real-time analysis and decision making. Industry is fast requiring Interactive analytical and decision making solutions to support the evolution of advanced clinical trial designs such as adaptive trials, which requires time reduction from data-in-the-database to the analysis of the data. Furthermore, industry is also prospecting frequent Interim Analysis and DMC review in a web-based, collaborative environment in a time-bound process to enable faster decision-making in an adaptive setup. Solutions that allow for high-performance computing enabling real time data analysis (especially the exploration of subsets) will work together to make the drug development process more efficient by supporting such advance approaches. Contact Us MaxisIT Inc 203 Main Street Metuchen, NJ 08840 Email: info@maxisit.com Phone: +1 732-494-2005, 1 - 877 - (629-4748).